In a syngeneic mouse model, melanoma tumors with high PD-L1 expression showed correspondingly higher Atezolizumab uptake in the tumor, compared to the aforementioned models (13.92 ± 1.0%ID/g, Table 1). Here, CD274 is linked to neoplasm.